ASHPOfficial

In this podcast, Dr. Dor Partosh and Dr. Dovena Lazaridis discuss the AJHP Practice Research Report, “Reducing readmissions with pharmacist-integrated care in Medicare value-based programs,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP welcomes Sarah Stephens and Drew Stivers as they discuss two medication safety sessions planned for the ASHP Pharmacy Futures meeting June 7–11 in Charlotte, NC. Both active in the medication safety community, they share reflections on the benefits of the meeting’s networking offerings as a genuine highlight of their personal and professional satisfaction with attending the event.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast focuses on member research and scholarly activity along with pearls and best practices for pharmacist-driven research.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Brandon Bookstaver and Dr. Kayla Stover discuss the AJHP theme issue on management of infectious diseases with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, Allison Porter is joined by the Section of Inpatient Care Practitioners 2024 Distinguished Service Awardee, Linda Spooner, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP is joined by Brody Maack for an overview of two interactive programs planned in Charlotte at the 2025 ASHP Pharmacy Futures Meeting. Along with Bonnie Kirschenbaum,  Brody will present Cracking the Code: Transforming Practice with Improved Billing Strategies.  

Joined By Evan Frasure,  Dr. Maack will tackle Bridging the Gap: Leveraging Implementation Science to Strengthen Controlled Substance Diversion Prevention Practices.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Tami Johnson and Dr. Anne Tucker discuss the AJHP Practice Research Report, “Pharmacy prevalence of second victim syndrome in a comprehensive cancer center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s Practice Advancement Initiative (PAI) 2030 provides pharmacists with the tools and guidance they need to continue to lead and shape the profession through 59 unique recommendations.  This podcast highlights 3 pharmacist success stories in health systems across the country where they have implemented changes utilizing the PAI 2030 recommendations. Our guests were able to implement new services in New York, North Dakota, and South Dakota, strengthening patient care for their health systems.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we explore the unique challenges pharmacy students and residents face during their training, including the risk of burnout, and discuss practical strategies for maintaining balance, building resilience, and fostering a sense of community. Our conversation highlights real-life experiences, expert advice, and actionable tips to help pharmacy learners prioritize their well-being while thriving in their professional journey. Whether you're navigating the demands of rotations, studying for boards, or managing the pressures of residency, this episode offers a refreshing perspective on sustaining your passion and purpose in pharmacy. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this session, pharmacists from three different types of community-based residency programs will discuss the implementation of a community-based residency training program within their pharmacies, highlight unique practice offerings, and career opportunities for graduates of these CPRPs. This podcast is an extension of a 2024 Midyear Clinical Meeting educational panel session.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.